Growth Metrics

Innoviva (INVA) Non Operating Investment Income (2020 - 2026)

Innoviva posted quarterly Non Operating Investment Income of $33.6 million for Q1 2026, up 151.42% year-on-year from $13.4 million in Q1 2025, and up 6.55% on a QoQ basis from $31.5 million in Q3 2025.

Innoviva (INVA) has 7 years of Non Operating Investment Income data on file, last reported at $33.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Investment Income rose 151.42% year-over-year to $33.6 million; the trailing twelve-month figure through Mar 2026 stood at $11.1 million (up 108.77% YoY), and the FY2025 full-year result was $20.2 million, up 134.08% from the prior year.
  • Non Operating Investment Income for Q1 2026 stood at $33.6 million, up from $31.5 million in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $33.6 million in Q1 2026 and bottomed at -$65.3 million in Q1 2025.
  • The 5-year median for Non Operating Investment Income is -$2.6 million (2023), against an average of -$6.0 million.
  • The widest annual swing landed in 2024, when Non Operating Investment Income slumped 36714.46%; it then soared 286.05% in 2025.
  • A 5-year view of Non Operating Investment Income shows it stood at -$10.2 million in 2022, then soared by 74.04% to -$2.6 million in 2023, then plunged by 541.52% to -$16.9 million in 2024, then jumped by 286.05% to $31.5 million in 2025, then increased by 6.55% to $33.6 million in 2026.
  • The last three Non Operating Investment Income figures came in at $33.6 million (Q1 2026), $31.5 million (Q3 2025), and $11.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 235,807.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 230,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn 33.58 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 33.58 Mn
Mar 31, 2026 33.58 Mn
Sep 30, 2025 31.51 Mn
Sep 30, 2025 31.51 Mn
Jun 30, 2025 11.28 Mn
Jun 30, 2025 11.28 Mn
Mar 31, 2025 -65.30 Mn
Mar 31, 2025 -65.30 Mn
Sep 30, 2024 -16.94 Mn
Sep 30, 2024 -16.94 Mn
Jun 30, 2024 -30.56 Mn
Jun 30, 2024 -30.56 Mn
Mar 31, 2024 -13.34 Mn
Mar 31, 2024 -13.34 Mn
Sep 30, 2023 -2.64 Mn
Sep 30, 2023 -2.64 Mn
Jun 30, 2023 -83,000.00
Jun 30, 2023 -83,000.00
Mar 31, 2023 -2.16 Mn
Mar 31, 2023 -2.16 Mn
Sep 30, 2022 -10.17 Mn
Sep 30, 2022 -10.17 Mn
Jun 30, 2022 -15.78 Mn
Jun 30, 2022 -15.78 Mn
Mar 31, 2022 2.54 Mn
Mar 31, 2022 2.54 Mn
Sep 30, 2021 33.61 Mn
Sep 30, 2021 33.61 Mn
Jun 30, 2021 45.32 Mn
Jun 30, 2021 45.32 Mn
Mar 31, 2021 55.05 Mn
Mar 31, 2021 55.05 Mn
Dec 31, 2020 -38.48 Mn
Dec 31, 2020 -38.48 Mn
Sep 30, 2020 -29.37 Mn
Sep 30, 2020 -29.37 Mn
Jun 30, 2020 46.70 Mn
Jun 30, 2020 46.70 Mn
Mar 31, 2020 21.92 Mn
Mar 31, 2020 21.92 Mn